Phase I trial of 131I-GMIB-Anti-HER2-VHH1, a new promising candidate for HER2-targeted radionuclide therapy in breast cancer patients.

Details

Language :

English

ISSN :

01615505

Volume :

61

Issue :

12

Database :

Complementary Index

Journal :

Journal of Nuclear Medicine

Publication Type :

Academic Journal

Accession number :

147491539

Full Text :

https://doi.org/10.2967/jnumed.120.255679